From 9th February 2019, market authorisation holders are required to place two safety features on all new packs of prescription medicines placed on the market in Europe.
Do you have your anti-tampering device (ATD) process in place? Scanners poised to communicate with the National Medicine Verification System (NMVS) ?
In order to comply with the requirements of FMD, pharmacy contractors will be required as part of the dispensing process to:
• check the anti-tampering device (ATD) to ensure it is intact prior to dispensing; and
• change the status of the pack in the UK’s National Medicines Verification System from “active” to “inactive—supplied”. This involves scanning the 2D barcode on each pack and communicating with the National Medicine Verification System (NMVS). This is where we can help, Contact Us Now >